ocr: TABLE 44.6-8. Ongoing Trials* in CSIand II Hodgkin's Disease Patients With Favorable Prognostic Features Trial Clinical Siage Patzents Arm I Arm 2 EORIC H7F I-II 332 STLI-splenic RT EBVP X 6 + IF EORTC H8F I-II 205 STLI-splenic RT MOPPABV X 3 +IF GHSG HD-7 I-lIt STLI-splenic RT ABVD X 2 + STLI-spleen Rome trial IIA 72 STLI-splenic RT ABVD X 1 + STLI-spleen Stanford University GI IA-IIA 78 SILI-splenic RT VBM X 6 + Reg EORTC, European Organization for the Research and Treatment of Cancer; GHSG, German Hodg- kin's Study Group; STLI-Splenic RT, subtotal ymphoid-splenic radiotherapy; MOPP, mechlor ...
